Skip to main content
. 2019 Oct 13;8(10):1671. doi: 10.3390/jcm8101671

Figure 3.

Figure 3

Changes in BP parameters (median and interquartile range) in patients receiving eplerenone for 6 weeks (n = 51) in relation to their baseline aldosteronism (A) and apnea–hypopnea index (AHI) (B)status. Asterisks indicate significant differences (* p < 0.05; ** p < 0.01; *** p < 0.001; Mann–Whitney U test).